Rogco LP’s Zimmer Biomet ZBH Stock Holding History

Rogco LP’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-35	Closed	-$4.62K	–	245
2024 Q1	$4.62K	Sell	35 -257	-88%	-$32.1K	﹤0.01%	218
2023 Q4	$35.5K	Hold	292	–	–	0.02%	146
2023 Q3	$32.8K	Buy	+292	New	+$37.1K	0.02%	147

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Rogco LP's ZBH Position: Q2 2024 in Review

Rogco LP sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 35 shares — an estimated $4.62K sold.

Rogco LP first reported a position in ZBH in Q3 2023 and held it in 3 quarters. The position peaked at $35.5K in Q4 2023. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

Rogco LP reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
Rogco LP sold 35 Zimmer Biomet shares in Q2 2024, an estimated $4.62K.
Rogco LP first reported a position in Zimmer Biomet in Q3 2023 and held it in 3 quarters.
Rogco LP's Zimmer Biomet position peaked at $35.5K in Q4 2023.
1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on Rogco LP's 13F filing for Q2 2024, filed 14 Aug 2024.